Heart valve engineering: Decellularized aortic homograft seeded with human cardiac stromal cells

Journal of Heart Valve Disease

Volumn 21, Issue 1, 2012, Pages 125-134

  Dainese, Luca ^a,b   Guarino, Anna ^b   Burba, Ilaria ^a   Esposito, Grazia ^c   Pompilio, Giulio ^a,b   Polvani, GianLuca ^a,b   Rossini, Alessandra ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; ANGIOGENIC FACTOR; GELATINASE A; TRYPSIN; VASCULOTROPIN; VON WILLEBRAND FACTOR; TRETOQUINOL;

ACETYLATION; AORTA GRAFT; ARTICLE; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PERMEABILIZATION; CELL POPULATION; CLINICAL ARTICLE; CRYOPRESERVATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HEART MUSCLE CELL; HEART VALVE; HEART VALVE ENGINEERING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEYDIG CELL; MALE; MESENCHYMAL STROMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; ZYMOGRAPHY; ADULT; ALLOTRANSPLANTATION; AORTA VALVE; BIOPROSTHESIS; GRAFT SURVIVAL; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; IMMUNOLOGY; INSTRUMENTATION; METHODOLOGY; PROSTHESIS FAILURE; TRANSPLANTATION;

ADULT; AORTIC VALVE; BIOPROSTHESIS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FEMALE; GRAFT SURVIVAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; PROSTHESIS FAILURE; TISSUE ENGINEERING; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS; TRETOQUINOL;

EID: 84860346715     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Dainese L, Biglioli P. Homograft and allograft: Could they have a future as a scaffold for engineered heart valves? J Cardiovasc Surg 2010;51;449-456
2. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-121
3. Knight RL, Booth C, Wilcox HE, Fisher J, Ingham E. Tissue engineering of cardiac valves: Re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J Heart Valve Dis 2005;14:806-813
4. Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395
5. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317
6. Iop L, Renier V, Naso F, et al. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 2009;30:4104-4116
7. Rossini A, Frati C, Lagrasta C, et al. Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin. Cardiovasc Res 2011;89:650-660
8. Rossini A, Zacheo A, Mocini D, et al. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 2008;44:683-693
9. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675
10. Meyns B, Jashari R, Gewillig M, et al. Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first. Eur J Cardiothorac Surg 2005;28:211-216; discussion 216
11. Troost E, Meyns B, Daenen W, et al. Homograft survival after tetralogy of Fallot repair: Determinants of accelerated homograft degeneration. Eur Heart J 2007;28:2503-2509
12. Mendelson K, Schoen FJ. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann Biomed Eng 2006;34:1799-1819
13. Cebotari S, Lichtenberg A, Tudorache I, et al. Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006;114(1 Suppl.):I132-I137
14. Schoen FJ. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008;118:1864-1880
15. Liao J, Joyce EM, Sacks MS. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 2008;29:1065-1074
16. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials 2006;27:3675-3683
17. Grauss RW, Hazekamp MG, Oppenhuizen F, van Munsteren CJ, Gittenberger-de Groot AC, DeRuiter MC. Histological evaluation of decellularised porcine aortic valves: Matrix changes due to different decellularisation methods. Eur J Cardiothorac Surg 2005;27:566-571
18. Zhou J, Fritze O, Schleicher M, et al. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity. Biomaterials 2010;31:2549-2554
19. Schmidt D, Stock UA, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci. 2007;362:1505-1512
20. Schenke-Layland K, Riemann I, Opitz F, König K, Halbhuber KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 2004;23:113-125
21. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171:1407-1418
22. Shi M, Liu Z-W, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011;164:1-8
23. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. Int J Biochem Cell Biol 2003;35:113-118
24. Miller DV, Edwards WD, Zehr KJ. Endothelial and smooth muscle cell populations in a decellularized cryopreserved aortic homograft (SynerGraft) 2 years after implantation. J Thorac Cardiovasc Surg 2006;132:175-176
25. .Vincentelli A, Wautot F, Juthier F, et al. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates? J Thorac Cardiovasc Surg 2007;134:424-432
26. Mol A, Smits AI, Bouten CV, Baaijens FP. Tissue engineering of heart valves: Advances and current challenges. Expert Rev Med Devices 2009;6:259-275
27. Baraki H, Tudorache I, Braun M, et al. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009;30:6240-6246
28. Vismara R, Soncini M, Talò G, et al. A bioreactor with compliance monitoring for heart valve grafts. Ann Biomed Eng 2010;38:100-108